DBVE regimen
Term · Oncology and biomedicine · MLC-T-ONC-002299
An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, ABVE regimen, and DBVE.
| Identifier | MLC-T-ONC-002299 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ABVE; ABVE regimen; DBVE |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002299",
"term": "DBVE regimen",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, ABVE regimen, and DBVE.",
"synonyms": [
"ABVE",
"ABVE regimen",
"DBVE"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/dbve-regimen/"
}
Record 5,724 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.